Manufacturing | Aspen inches toward COVID shot licensing deal with J&J | Fraiser Kansteiner | https://www.fiercepharma.com/manufacturing/aspen-closes-talks-to-license-j-j-s-co... | https://www.fiercepharma.com/manufacturing | Nov 30, 2021, 10:15 AM | https://www.fiercepharma.com/manufacturing/aspen-closes-talks-to-license-j-j-s-co... | https://www.fiercepharma.com/author/fraiser-kansteiner | One of Johnson & Johnson’s pandemic manufacturing partners just made headway in i... | by Fraiser Kansteiner | Nov 30, 2021, 10:15 AM | https://www.fiercepharma.com/manufacturing/aspen-closes-talks-to-license-j-j-s-co... | Manufacturing | https://www.fiercepharma.com/author/fraiser-kansteiner | Fraiser Kansteiner | One of Johnson & Johnson’s pandemic manufacturing partners just made headway in i... | https://www.fiercepharma.com/manufacturing/aspen-closes-talks-to-license-j-j-s-co... | Aspen inches toward COVID shot licensing deal with J&J | https://www.fiercepharma.com/manufacturing | | https://www.fiercepharma.com/ | https://www.fiercepharma.com/ | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC |
Marketing | Acadia tackles Parkinson's psychosis stigma via personal stories | Natalie Missakian | https://www.fiercepharma.com/marketing/acadia-enlists-storycorps-for-bilingual-ca... | https://www.fiercepharma.com/marketing | Nov 30, 2021, 10:00 AM | https://www.fiercepharma.com/marketing/acadia-enlists-storycorps-for-bilingual-ca... | https://www.fiercepharma.com/author/natalie-missakian | Acadia hopes to get patients to open up about Parkinson's disease-related halluci... | by Natalie Missakian | Nov 30, 2021, 10:00 AM | https://www.fiercepharma.com/marketing/acadia-enlists-storycorps-for-bilingual-ca... | Marketing | https://www.fiercepharma.com/author/natalie-missakian | Natalie Missakian | Acadia hopes to get patients to open up about Parkinson's disease-related halluci... | https://www.fiercepharma.com/marketing/acadia-enlists-storycorps-for-bilingual-ca... | Acadia tackles Parkinson's psychosis stigma via personal stories | https://www.fiercepharma.com/marketing | | https://www.fiercepharma.com/ | https://www.fiercepharma.com/ | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC |
Pharma | A court has declined to revive a patent on Biogen's Tecfidera | Fraiser Kansteiner | https://www.fiercepharma.com/pharma/biogen-s-appeal-for-tecfidera-patent-revival-... | https://www.fiercepharma.com/pharma | Nov 30, 2021, 3:08 PM | https://www.fiercepharma.com/pharma/biogen-s-appeal-for-tecfidera-patent-revival-... | https://www.fiercepharma.com/author/fraiser-kansteiner | Despite Biogen's best efforts, the threat of Tecfidera generics seem here to stay... | by Fraiser Kansteiner | Nov 30, 2021, 3:08 PM | https://www.fiercepharma.com/pharma/biogen-s-appeal-for-tecfidera-patent-revival-... | Pharma | https://www.fiercepharma.com/author/fraiser-kansteiner | Fraiser Kansteiner | Despite Biogen's best efforts, the threat of Tecfidera generics seem here to stay... | https://www.fiercepharma.com/pharma/biogen-s-appeal-for-tecfidera-patent-revival-... | A court has declined to revive a patent on Biogen's Tecfidera | https://www.fiercepharma.com/pharma | | https://www.fiercepharma.com/ | https://www.fiercepharma.com/ | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC |
Pharma | Amgen has delayed the entry of another Enbrel biosimilar | Fraiser Kansteiner | https://www.fiercepharma.com/pharma/amgen-stalls-samsung-s-enbrel-biosim-until-20... | https://www.fiercepharma.com/pharma | Dec 1, 2021, 9:25 AM | https://www.fiercepharma.com/pharma/amgen-stalls-samsung-s-enbrel-biosim-until-20... | https://www.fiercepharma.com/author/fraiser-kansteiner | Samsung Bioepis, like Sandoz before it, won't be able to sell its biosimilar vers... | by Fraiser Kansteiner | Dec 1, 2021, 9:25 AM | https://www.fiercepharma.com/pharma/amgen-stalls-samsung-s-enbrel-biosim-until-20... | Pharma | https://www.fiercepharma.com/author/fraiser-kansteiner | Fraiser Kansteiner | Samsung Bioepis, like Sandoz before it, won't be able to sell its biosimilar vers... | https://www.fiercepharma.com/pharma/amgen-stalls-samsung-s-enbrel-biosim-until-20... | Amgen has delayed the entry of another Enbrel biosimilar | https://www.fiercepharma.com/pharma | | https://www.fiercepharma.com/ | https://www.fiercepharma.com/ | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC |
Pharma | Bristol Myers up for high-stakes FDA autoimmune drug decision | Angus Liu | https://www.fiercepharma.com/pharma/bristol-myers-squibb-enters-fda-review-high-s... | https://www.fiercepharma.com/pharma | Nov 30, 2021, 11:47 AM | https://www.fiercepharma.com/pharma/bristol-myers-squibb-enters-fda-review-high-s... | https://www.fiercepharma.com/author/angus-liu | Deucravacitinib targets TYK2, a member of the JAK family, where drugs have recent... | by Angus Liu | Nov 30, 2021, 11:47 AM | https://www.fiercepharma.com/pharma/bristol-myers-squibb-enters-fda-review-high-s... | Pharma | https://www.fiercepharma.com/author/angus-liu | Angus Liu | Deucravacitinib targets TYK2, a member of the JAK family, where drugs have recent... | https://www.fiercepharma.com/pharma/bristol-myers-squibb-enters-fda-review-high-s... | Bristol Myers up for high-stakes FDA autoimmune drug decision | https://www.fiercepharma.com/pharma | | https://www.fiercepharma.com/ | https://www.fiercepharma.com/ | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC |
Pharma | Deciphera reduces workforce by 35%, cuts development of 2 drugs | Kevin Dunleavy | https://www.fiercepharma.com/pharma/after-flunking-trial-deciphera-cuts-140-jobs-... | https://www.fiercepharma.com/pharma | Nov 30, 2021, 2:00 PM | https://www.fiercepharma.com/pharma/after-flunking-trial-deciphera-cuts-140-jobs-... | https://www.fiercepharma.com/author/kevin-dunleavy | After a devastating trial flop, Deciphera will cut 140 jobs, reducing its headcou... | by Kevin Dunleavy | Nov 30, 2021, 2:00 PM | https://www.fiercepharma.com/pharma/after-flunking-trial-deciphera-cuts-140-jobs-... | Pharma | https://www.fiercepharma.com/author/kevin-dunleavy | Kevin Dunleavy | After a devastating trial flop, Deciphera will cut 140 jobs, reducing its headcou... | https://www.fiercepharma.com/pharma/after-flunking-trial-deciphera-cuts-140-jobs-... | Deciphera reduces workforce by 35%, cuts development of 2 drugs | https://www.fiercepharma.com/pharma | | https://www.fiercepharma.com/ | https://www.fiercepharma.com/ | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC |
Pharma | GSK expects the future of HIV treatment to be injectable | Fraiser Kansteiner | https://www.fiercepharma.com/pharma/gsk-sviiv-looks-to-future-injectable-hiv-trea... | https://www.fiercepharma.com/pharma | Nov 30, 2021, 11:10 AM | https://www.fiercepharma.com/pharma/gsk-sviiv-looks-to-future-injectable-hiv-trea... | https://www.fiercepharma.com/author/fraiser-kansteiner | On the prevention front, GSK’s PrEP opportunity remains “unrealized,” SVB Leerink... | by Fraiser Kansteiner | Nov 30, 2021, 11:10 AM | https://www.fiercepharma.com/pharma/gsk-sviiv-looks-to-future-injectable-hiv-trea... | Pharma | https://www.fiercepharma.com/author/fraiser-kansteiner | Fraiser Kansteiner | On the prevention front, GSK’s PrEP opportunity remains “unrealized,” SVB Leerink... | https://www.fiercepharma.com/pharma/gsk-sviiv-looks-to-future-injectable-hiv-trea... | GSK expects the future of HIV treatment to be injectable | https://www.fiercepharma.com/pharma | | https://www.fiercepharma.com/ | https://www.fiercepharma.com/ | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC |
Pharma | Merck's COVID-19 antiviral clears FDA committee by narrow vote | Kevin Dunleavy | https://www.fiercepharma.com/pharma/by-narrow-vote-fda-advisory-committee-recomme... | https://www.fiercepharma.com/pharma | Nov 30, 2021, 6:26 PM | https://www.fiercepharma.com/pharma/by-narrow-vote-fda-advisory-committee-recomme... | https://www.fiercepharma.com/author/kevin-dunleavy | An FDA advisory committee voted 13-10 to endorse the use of Merck and Ridgeback's... | by Kevin Dunleavy | Nov 30, 2021, 6:26 PM | https://www.fiercepharma.com/pharma/by-narrow-vote-fda-advisory-committee-recomme... | Pharma | https://www.fiercepharma.com/author/kevin-dunleavy | Kevin Dunleavy | An FDA advisory committee voted 13-10 to endorse the use of Merck and Ridgeback's... | https://www.fiercepharma.com/pharma/by-narrow-vote-fda-advisory-committee-recomme... | Merck's COVID-19 antiviral clears FDA committee by narrow vote | https://www.fiercepharma.com/pharma | | https://www.fiercepharma.com/ | https://www.fiercepharma.com/ | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC |
| Redefining the Therapeutic Approach in Advanced Gastric Cancer | Daiichi Sankyo and AstraZeneca | https://www.fiercepharma.com/sponsored/shifting-conversation-and-redefining-thera... | | Nov 29, 2021, 8:00 AM | https://www.fiercepharma.com/sponsored/shifting-conversation-and-redefining-thera... | https://www.fiercepharma.com/author/daiichi-sankyo-and-astrazeneca | Read more about how the conversation is shifting around the treatment of this dis... | Sponsored by Daiichi Sankyo and AstraZeneca | Nov 29, 2021, 8:00 AM | https://www.fiercepharma.com/sponsored/shifting-conversation-and-redefining-thera... | | https://www.fiercepharma.com/author/daiichi-sankyo-and-astrazeneca | Daiichi Sankyo and AstraZeneca | Read more about how the conversation is shifting around the treatment of this dis... | https://www.fiercepharma.com/sponsored/shifting-conversation-and-redefining-thera... | Redefining the Therapeutic Approach in Advanced Gastric Cancer | | | https://www.fiercepharma.com/ | https://www.fiercepharma.com/ | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC |
| Using Data Responsibly to Solve Health Equity Challenges | Onduo, a Verily Company | https://www.fiercepharma.com/sponsored/solving-challenge-health-equity-data-great... | | Nov 29, 2021, 8:00 AM | https://www.fiercepharma.com/sponsored/solving-challenge-health-equity-data-great... | https://www.fiercepharma.com/author/onduo-a-verily-company | How the use of data analysis - and a commitment to making health more equitable -... | Sponsored by Onduo, a Verily Company | Nov 29, 2021, 8:00 AM | https://www.fiercepharma.com/sponsored/solving-challenge-health-equity-data-great... | | https://www.fiercepharma.com/author/onduo-a-verily-company | Onduo, a Verily Company | How the use of data analysis - and a commitment to making health more equitable -... | https://www.fiercepharma.com/sponsored/solving-challenge-health-equity-data-great... | Using Data Responsibly to Solve Health Equity Challenges | | | https://www.fiercepharma.com/ | https://www.fiercepharma.com/ | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC | 2021-12-02 03:51:48 UTC |